In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line ...

MARLBOROUGH, Mass., Dec. 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE™ ...

SAN DIEGO, Calif. (Ivanhoe Newswire) - Atrial fibrillation, or AFib, is the most common type of heart arrhythmia. It’s estimated 12 million people in the U.S. are living with it. If not treated, it ...

CHRISTUS Highland Medical Center announced that it is the first hospital in Louisiana to perform a new atrial fibrillation procedure using the Boston Scientific Farapulse Pulsed Field Ablation system, ...

PADUCAH, Ky. (KFVS) - Baptist Health Paducah is offering a new device to treat intermittent atrial fibrillation or an irregularly fast heart rate. According to a release from Baptist Health, Vedran ...

Boston Scientific recently achieved FDA approval to expand the FARAPULSE™ Pulsed Field Ablation (PFA) System's use, enhancing treatment options for persistent atrial fibrillation. This significant ...

Boston Scientific's FARADISE registry study is due to run for another two years before its completion in 2027. Image credit: Mehaniq via Shutterstock.com. · Medical Device Network · Mehaniq via ...

AI performed well in conducting preliminary readings of heart ultrasounds - Copyright AFP Fabrice COFFRINI AI performed well in conducting preliminary readings of ...

- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") today announced ...

Dr. Steven Mickelsen dreamed up a new way to treat a heart condition called atrial fibrillation while finishing a medical fellowship at the University of Iowa in 2012. His idea of using pulsed ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Allan Zingeler, Raju Viswanathan, PhD, and Michael Mahoney of Boston Scientific have been awarded the inaugural Thomas J. Fogarty Prize (Fogarty Prize) for the ...